Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL, cilt.21, sa.9, ss.1159-1171, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 21 Sayı: 9
- Basım Tarihi: 2015
- Doi Numarası: 10.1177/1352458514559865
- Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1159-1171
- Anahtar Kelimeler: Multiple sclerosis, treatment outcomes, patient registry, real-world date, propensity score, relapses, disability, MULTICENTER, REBIF, BIAS
- Karadeniz Teknik Üniversitesi Adresli: Evet
Özet
Background: The results of head-to-head comparisons of injectable immunomodulators (interferon , glatiramer acetate) have been inconclusive and a comprehensive analysis of their effectiveness is needed.